ProfileGDS4718 / 203619_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 42% 62% 40% 42% 59% 31% 43% 43% 41% 43% 45% 44% 62% 71% 56% 44% 47% 75% 61% 39% 47% 40% 44% 42% 67% 42% 42% 42% 44% 82% 63% 37% 32% 78% 63% 45% 46% 45% 61% 43% 51% 63% 46% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.8853338
GSM549102patient 115, normal, homogenized [OPG study]5.1372742
GSM549104patient 119, normal, homogenized [OPG study]6.3025462
GSM549108patient 138, normal, homogenized [OPG study]5.0665240
GSM549119patient 077, normal, homogenized [OPG study]5.0899242
GSM549133patient 032, cancer, homogenized [OPG study]6.0049859
GSM549139patient 042, cancer, homogenized [OPG study]4.552531
GSM549099patient 107, normal, homogenized [OPG study]5.1657643
GSM549109patient 139, normal, homogenized [OPG study]5.1729443
GSM549110patient 046, normal, homogenized [OPG study]5.061141
GSM549114patient 063, normal, homogenized [OPG study]5.0947143
GSM549122patient 082, normal, homogenized [OPG study]5.2249145
GSM549134patient 033, cancer, homogenized [OPG study]5.1762144
GSM549136patient 036, cancer, homogenized [OPG study]6.2521762
GSM549140patient 044, cancer, homogenized [OPG study]7.0458171
GSM549111patient 047, normal, homogenized [OPG study]5.872956
GSM549113patient 057, normal, homogenized [OPG study]5.1331544
GSM549132patient 031, cancer, homogenized [OPG study]5.3606547
GSM549137patient 038, cancer, homogenized [OPG study]7.3875
GSM549142patient 047, cancer, homogenized [OPG study]6.2783461
GSM549100patient 110, normal, homogenized [OPG study]4.96439
GSM549107patient 135, normal, homogenized [OPG study]5.3203647
GSM549115patient 068, normal, homogenized [OPG study]4.9567140
GSM549116patient 072, normal, homogenized [OPG study]5.1741344
GSM549120patient 078, normal, homogenized [OPG study]5.1024142
GSM549131patient 030, cancer, homogenized [OPG study]6.6520567
GSM549118patient 074, normal, homogenized [OPG study]5.102342
GSM549129patient 027, cancer, homogenized [OPG study]5.0850542
GSM549123patient 088, normal, homogenized [OPG study]5.0821942
GSM549124patient 006, cancer, homogenized [OPG study]5.2165744
GSM549126patient 015, cancer, homogenized [OPG study]8.0936282
GSM549128patient 025, cancer, homogenized [OPG study]6.3924663
GSM549103patient 117, normal, homogenized [OPG study]4.9036837
GSM549117patient 073, normal, homogenized [OPG study]4.6085732
GSM549138patient 041, cancer, homogenized [OPG study]7.6673178
GSM549141patient 045, cancer, homogenized [OPG study]6.3856963
GSM549130patient 028, cancer, homogenized [OPG study]5.2678745
GSM549101patient 111, normal, homogenized [OPG study]5.3060346
GSM549105patient 128, normal, homogenized [OPG study]5.2592445
GSM549106patient 134, normal, homogenized [OPG study]6.1707161
GSM549112patient 048, normal, homogenized [OPG study]5.1320143
GSM549125patient 011, cancer, homogenized [OPG study]5.5947251
GSM549127patient 024, cancer, homogenized [OPG study]6.4258263
GSM549135patient 035, cancer, homogenized [OPG study]5.2481146